Optimum Platelet Inhibition After Coronary Bypass Surgery
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To investigate the effect of different dosages of aspirin on platelet aggregation and to
determine the possible mechanisms of aspirin resistance, we intend to compare the effects of
low, medium dose aspirin with clopidogrel (an alternative antiplatelet agent) in patients
after coronary artery bypass surgery.